IMAX

IMAXNYSEUSD

THESIS ALERT

Email me when the IMAX thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$48.81
−$0.10 (−0.20%)Today 1M −3.92%
After hours$48.810.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$48.91
Prior regular-session close from the quote source.
$47.87–$49.06
Regular-session low and high so far today.
870.1K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 24 projected
Projected for 2027-02-24 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$32.71–$57.73
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own IMAX if its brand remains the must-have premium theatrical format for event movies, allowing a cyclical box-office recovery to convert into high-margin cash rather than just one-off hit-film revenue.

IMAX price history

Latest price$48.81Today−$0.10 (-0.20%)
IMAX -5.13%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Studios and exhibitors keep using IMAX as the premium event-release channel because its brand and technical format can lift per-screen economics versus ordinary auditoriums and competing premium large formats.HoldingMateriality: High

    GAAP annual revenue rose from $352.2 million in FY2024 to $410.2 million in FY2025, recovering above the FY2023 level of $374.8 million. If IMAX remains the preferred event channel, demand converts into recurring network revenue; if not, the company becomes a cyclical theater-equipment vendor.

    Watch: Major studios such as Disney, Warner Bros. Discovery, Universal, or Paramount shift premium marketing and screen allocation toward Dolby Cinema, ScreenX, 4DX, or exhibitor-owned PLFs instead of IMAX.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual revenue rose from $352.2 million in FY2024 to $410.2 million in FY2025, recovering above the FY2023 level of.

    Open source ↗
  • IMAX’s network and technology economics retain enough pricing power that incremental box-office activity converts into premium gross profit rather than being competed down like commodity cinema equipment.StrengtheningMateriality: High

    GAAP annual gross profit increased from $190.2 million in FY2024 to $246.2 million in FY2025, faster than revenue growth over the same period. This is what separates a valuable platform from a low-margin hardware cycle.

    Watch: Dolby Cinema, ScreenX, 4DX, Cinemark XD, or other PLF alternatives discount aggressively and force IMAX to reduce revenue share or installation economics.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual gross profit increased from $190.2 million in FY2024 to $246.2 million in FY2025, faster than revenue growth over.

    Open source ↗
  • The fixed technology, remastering, and network-support cost base remains scalable enough that recovered slate and network activity expand GAAP operating income without requiring proportional overhead growth.StrengtheningMateriality: Medium

    GAAP annual operating income rose from $43.9 million in FY2024 to $84.2 million in FY2025 while revenue rose from $352.2 million to $410.2 million. Operating leverage is the path from box-office relevance to meaningful owner earnings.

    Watch: IMAX must materially increase R&D or capex-like spending to keep its projection, sound, and theater technology differentiated from Dolby and exhibitor-owned PLFs.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating income rose from $43.9 million in FY2024 to $84.2 million in FY2025 while revenue rose from $352.2.

    Open source ↗
  • IMAX’s customer economics and contract structure keep the business cash-generative enough to fund technology refresh, network growth, and balance-sheet flexibility internally.StrengtheningMateriality: Medium

    GAAP annual operating cash flow increased from $70.8 million in FY2024 to $127.1 million in FY2025. Self-funded growth lowers financial risk and gives management room to invest through box-office cycles.

    Watch: A prolonged exhibitor capex freeze at AMC, Cineworld/Regal, or large international chains slows system deployments and shifts more funding burden to IMAX.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating cash flow increased from $70.8 million in FY2024 to $127.1 million in FY2025.

    Open source ↗
  • Per-share value creation depends on IMAX turning episodic blockbuster success into repeatable premium-network monetization rather than leaving EPS hostage to a few hit films.HoldingMateriality: Medium

    GAAP diluted EPS improved from a loss of $0.40 in FY2022 to positive $0.46 in FY2023, $0.48 in FY2024, and $0.63 in FY2025. A repeatable network model deserves a different valuation than a slate-dependent earnings spike.

    Watch: The post-strike film pipeline becomes concentrated in too few tentpoles, making IMAX results dependent on a small number of franchise outcomes.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP diluted EPS improved from a loss of $0.40 in FY2022 to positive $0.46 in FY2023, $0.48 in FY2024, and.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Studios and exhibitors keep using IMAX as the premium event-release channel because its brand and technical format can lift per-screen economics versus ordinary auditoriums and competing premium large formats. If IMAX remains the preferred event channel, demand converts into recurring network revenue; if not, the company becomes a cyclical theater-equipment vendor.

IMAX’s network and technology economics retain enough pricing power that incremental box-office activity converts into premium gross profit rather than being competed down like commodity cinema equipment. This is what separates a valuable platform from a low-margin hardware cycle.

The fixed technology, remastering, and network-support cost base remains scalable enough that recovered slate and network activity expand GAAP operating income without requiring proportional overhead growth. Operating leverage is the path from box-office relevance to meaningful owner earnings.

IMAX’s customer economics and contract structure keep the business cash-generative enough to fund technology refresh, network growth, and balance-sheet flexibility internally. Self-funded growth lowers financial risk and gives management room to invest through box-office cycles.

Per-share value creation depends on IMAX turning episodic blockbuster success into repeatable premium-network monetization rather than leaving EPS hostage to a few hit films. A repeatable network model deserves a different valuation than a slate-dependent earnings spike.

All standing thesis claims
Original report summary

its brand remains the must-have premium theatrical format for event movies, allowing a cyclical box-office recovery to convert into high-margin cash rather than just one-off hit-film revenue.

Evidence assessed Oct 15, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for IMAX

Where the evidence on IMAX stands: Holding on the latest evidence (Oct 15, 2026). Of its 5 thesis points, 3 strengthening and 2 holding.

Bull case: what the evidence supports

  • Studios and exhibitors keep using IMAX as the premium event-release channel because its brand and technical format can lift per-screen economics versus ordinary auditoriums and competing premium large formats.

    sec.gov ↗

  • IMAX’s network and technology economics retain enough pricing power that incremental box-office activity converts into premium gross profit rather than being competed down like commodity cinema equipment.

    sec.gov ↗

  • The fixed technology, remastering, and network-support cost base remains scalable enough that recovered slate and network activity expand GAAP operating income without requiring proportional overhead growth.

    sec.gov ↗

  • IMAX’s customer economics and contract structure keep the business cash-generative enough to fund technology refresh, network growth, and balance-sheet flexibility internally.

    sec.gov ↗

  • Per-share value creation depends on IMAX turning episodic blockbuster success into repeatable premium-network monetization rather than leaving EPS hostage to a few hit films.

    sec.gov ↗

Bear case: what would count against it

  • Major studios such as Disney, Warner Bros. Discovery, Universal, or Paramount shift premium marketing and screen allocation toward Dolby Cinema, ScreenX, 4DX, or exhibitor-owned PLFs instead of IMAX.

    sec.gov ↗

  • Dolby Cinema, ScreenX, 4DX, Cinemark XD, or other PLF alternatives discount aggressively and force IMAX to reduce revenue share or installation economics.

    sec.gov ↗

  • IMAX must materially increase R&D or capex-like spending to keep its projection, sound, and theater technology differentiated from Dolby and exhibitor-owned PLFs.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · IMAX

Loading the break-condition record for IMAX.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Director or principal officer change.

    IMAX filed an SEC 8-K on 2026-08-21: Director or principal officer change. It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    IMAX filed an SEC 8-K on 2026-07-23: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    IMAX filed an SEC 8-K on 2026-04-30: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Major studios such as Disney, Warner Bros. Discovery, Universal, or Paramount shift premium marketing and screen allocation toward Dolby Cinema, ScreenX, 4DX, or exhibitor-owned PLFs instead of IMAX.
  • Dolby Cinema, ScreenX, 4DX, Cinemark XD, or other PLF alternatives discount aggressively and force IMAX to reduce revenue share or installation economics.
  • IMAX must materially increase R&D or capex-like spending to keep its projection, sound, and theater technology differentiated from Dolby and exhibitor-owned PLFs.
  • A prolonged exhibitor capex freeze at AMC, Cineworld/Regal, or large international chains slows system deployments and shifts more funding burden to IMAX.
  • The post-strike film pipeline becomes concentrated in too few tentpoles, making IMAX results dependent on a small number of franchise outcomes.

IMAX news

Loading headlines…

Financial statements

IMAX income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

IMAX: quick answers

When does IMAX (IMAX) report earnings next?
IMAX's next results are projected for February 24, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 5, 2026. Earnings calendar
What is IMAX's short interest?
As of October 30, 2026, 6.7M IMAX shares were sold short, 12.1% of its shares outstanding, down 3.5% from the count before. At the stock's average daily volume that is 8.0 days to cover. FINRA publishes the count twice a month. IMAX short interest history
Have members of Congress traded IMAX?
6 trades in IMAX have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed IMAX trade
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.